Neuropeptide y and gamma-melanocyte stimulating hormone (γ-MSH) share a common pressor mechanism of action

Endocrine

Volumn 35, Issue 3, 2009, Pages 312-324

  Gruber, Kenneth A ^a   Fan, Wei ^a   Akerberg, Helena ^b   Larhammar, Dan ^b   Chee, Melissa J S ^c   Colmers, William F ^c   Cone, Roger D ^a,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF ALBERTA   (Canada)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; Central vasopressin system; Hypertensive effects; Neuropeptide Y; RFamide peptides; RFamide receptors; Y1 antagonists; MSH

Indexed keywords

GAMMA INTERMEDIN; MELANOCORTIN RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE; ARGININE; DRUG DERIVATIVE; HORMONE ANTAGONIST; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR RESPONSE; CONTROL SYSTEM; HORMONE ACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEQUENCE ANALYSIS; ADRENERGIC SYSTEM; ANIMAL; CARDIOVASCULAR FUNCTION; CELL CULTURE; CHO CELL; CRICETULUS; DRUG ANTAGONISM; DRUG EFFECT; ENERGY METABOLISM; HAMSTER; MALE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; ENERGY METABOLISM; GAMMA-MSH; HORMONE ANTAGONISTS; HUMANS; MALE; MICE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASOMOTOR SYSTEM;

EID: 70149087276     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-008-9141-3     Document Type: Article

References (69)

1. AM Wolf GA Colditz 1998 Current estimates of the economic cost of obesity in the United States Obes. Res. 6 97 106 9545015 1:STN:280:DyaK1c3gsVGktA%3D%3D
2. MW Schwartz SC Woods D Porte Jr RJ Seeley DG Baskin 2000 Central nervous system control of food intake Nature 404 661 671 10766253 1:CAS:528: DC%2BD3cXis1Grur4%3D
3. RP Wildman D Gu K Reynolds X Duan X Wu J He 2005 Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults? Am. J. Clin. Nutr. 82 1195 1202 16332651 1:CAS:528: DC%2BD2MXhtlehurbK
4. RD Cone 2005 Anatomy and regulation of the central melanocortin system Nat. Neurosci. 8 571 578 15856065 10.1038/nn1455 1:CAS:528:DC%2BD2MXjsFyktbo%3D (Pubitemid 40594196)
5. SP Kalra PS Kalra 2004 NPY-an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction Peptides 25 465 471 15134867 10.1016/j.peptides.2004.03.001 1:CAS:528:DC%2BD2cXjvVagtbw%3D (Pubitemid 38591556)
6. RS Ahima JS Flier 2000 Leptin Annu. Rev. Physiol. 62 413 437 10845097 10.1146/annurev.physiol.62.1.413 1:CAS:528:DC%2BD3cXltlGrsbs%3D (Pubitemid 30618269)
7. JJ Kuo AA Silva JE Hall 2003 Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function Hypertension 41 768 774 12623994 10.1161/01.HYP.0000048194.97428.1A 1:CAS:528:DC%2BD3sXhsFWktLw%3D (Pubitemid 36314589)
8. XP Ni AA Butler RD Cone MH Humphreys 2006 Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones J. Hypertens. 24 2239 2246 17053546 10.1097/01.hjh.0000249702.49854.fa 1:CAS:528:DC%2BD28XhtV2rs7zO (Pubitemid 44611033)
9. MF Callahan RF Kirby AK Johnson KA Gruber 1988 Sympathetic terminal mediation of the acute cardiovascular response of gamma 2-MSH J. Auton. Nerv. Syst. 24 179 182 2850308 10.1016/0165-1838(88)90146-4 1:CAS:528: DyaL1MXltFGntw%3D%3D (Pubitemid 18267999)
10. MF Callahan RF Kirby JR Lymangrover AK Johnson KA Gruber 1984 Cardiovascular mechanisms of gamma (gamma) 2-MSH Clin. Exp. Hypertens. A Theory Prac. 6 1727 1730 10.3109/10641968409046067 1:STN:280:DyaL2M7nslGjuw%3D%3D
11. MF Callahan RF Kirby DW Wolff JW Strandhoy JR Lymangrover AK Johnson KA Gruber 1985 Sympathetic nervous system mediation of acute cardiovascular actions of gamma 2-melanocyte-stimulating hormone Hypertension 7 I145 I150 2860063 1:STN:280:DyaL2M3gs1ajtA%3D%3D
12. JR Martin MM Knuepfer MC Beinfeld TC Westfall 1989 Mechanism of pressor response to posterior hypothalamic injection of neuropeptide Y Am. J. Physiol. 257 H791 H798 2782438 1:CAS:528:DyaL1MXlvVyht7s%3D
13. M Vallejo SL Lightman 1986 Pressor effect of centrally administered neuropeptide Y in rats, role of sympathetic nervous system and vasopressin Life Sci. 38 1859 1866 3084899 10.1016/0024-3205(86)90141-4 1:CAS:528: DyaL28XitF2ku7g%3D (Pubitemid 16068746)
14. GJ Dockray 2004 The expanding family of -RFamide peptides and their effects on feeding behaviour Exp. Physiol. 89 3 229 235 15123557 10.1113/expphysiol.2004.027169 1:CAS:528:DC%2BD2cXkvFCiu70%3D (Pubitemid 38660035)
15. Y Dumont A Cadieux H Doods A Fournier R Quirion 2000 Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems, BIB03304 (Y1) and CGP71683A (Y5) Can. J. Physiol. Pharmacol. 78 116 125 10737674 10.1139/cjpp-78-2-116 1:CAS:528:DC%2BD3cXhsVKgu7Y%3D
16. Q Fang J Guo F He YL Peng M Chang R Wang 2006 In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist Peptides 27 2207 2213 16762456 10.1016/j.peptides.2006.04.002 1:CAS:528:DC%2BD28Xot1Wks7o%3D (Pubitemid 44189628)
17. Q Fang J Guo M Chang LX Chen Q Chen R Wang 2005 Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon Peptides 26 791 797 15808909 10.1016/j.peptides.2004.12.009 1:CAS:528:DC%2BD2MXjt1KjsrY%3D (Pubitemid 40461660)
18. C Mollereau C Gouarderes Y Dumont M Kotani M Detheux H Doods M Parmentier R Quirion JM Zajac 2001 Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226 Br. J. Pharmacol. 133 1 4 11325787 10.1038/sj.bjp.0704049 1:CAS:528:DC%2BD3MXjs1aju7c%3D
19. C Mollereau H Mazarguil D Marcus I Quelven M Kotani V Lannoy Y Dumont R Quirion M Detheux M Parmentier JM Zajac 2002 Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists Eur. J. Pharmacol. 451 245 256 12242085 10.1016/S0014-2999(02)02224-0 1:CAS:528:DC%2BD38XntVajs7w%3D (Pubitemid 35254027)
20. KA Gruber SL Eskridge 1986 Central vasopressin system medication of acute pressor effect of γ-MSH Am. J. Physiol. 251 E134 E137 3014888 1:CAS:528:DyaL28XkvFWltbY%3D
21. G D'Angelo JS Pollock DM Pollock 2005 Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor Am. J. Physiol. Heart Circ. Physiol. 288 H1829 H1835 15563533 10.1152/ajpheart.00844. 2004 (Pubitemid 40418010)
22. I Lundell MA Statnick D Johnson DA Schober P Starback DR Gehlert D Larhammar 1996 The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor Proc. Natl. Acad. Sci. USA 93 5111 5115 8643536 10.1073/pnas.93.10.5111 1:CAS:528:DyaK28XjtVKlurs%3D (Pubitemid 26162879)
23. D Mullins D Kirby K Hwa M Guzzi J Rivier E Parker 2000 Identification of potent and selective neuropeptide Y Y(1) receptor antagonists with orexigenic activity in vivo Mol. Pharmacol. 60 534 540
24. P Balse-Srinivasan P Grieco M Cai D Trivedi VJ Hruby 2003 Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues J. Med. Chem. 46 4965 4973 14584947 10.1021/jm030119t 1:CAS:528:DC%2BD3sXnvVegt7s%3D
25. MJ Nijsen GJ deRuiter CM Kasbergen P Hoogerhaut DJ deWildt 2000 Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats Br. J. Pharmacol. 131 7 1468 1474 11090122 10.1038/sj.bjp.0703709 1:CAS:528: DC%2BD3cXovFygur8%3D
26. DA Kirby SC Koerber JM May C Hagaman MJ Cullen MA Pelleymounter JE Rivier 1995 Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass J. Med. Chem. 38 4579 4586 7473586 10.1021/jm00022a024 1:CAS:528:DyaK2MXosV2qsb4%3D
27. JA Bonini KA Jones N Adham C Forray R Artymyshyn MM Durkin KE Smith JA Tamm LW Boteju PP Lakhlani R Raddatz WJ Yao KL Ogozalek N Boyle EV Kouranova Y Quan PJ Vaysse JM Wetzel TA Branchek C Gerald B Borowsky 2000 Identification and characterization of two G protein-coupled receptors for neuropeptide FF J. Biol. Chem. 275 39324 39331 11024015 10.1074/jbc.M004385200 1:CAS:528: DC%2BD3cXptFSrsLc%3D (Pubitemid 32058954)
28. SE Jarvis JM Magga AM Beedle JE Braun GW Zamponi 2000 G protein modulation of N-type calcium channels is facilitated by physical interactions between syntaxin 1A and Gbetagamma J. Biol. Chem. 275 6388 6394 10692440 10.1074/jbc.275.9.6388 1:CAS:528:DC%2BD3cXhslWrt7g%3D (Pubitemid 30129934)
29. C Cabrele AG Beck-Sickinger 2000 Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family J. Pept. Sci. 6 97 122 10759209 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E 1:CAS:528:DC%2BD3cXitlGitrs%3D (Pubitemid 30179494)
30. J Fuhlendorff U Gether L Askerlund N Langeland-Johassen H Thogersen SG Melberg UB Olsen O Thastrup TW Schwartz 1990 [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist Proc. Natl. Acad. Sci. USA 87 182 186 2153286 10.1073/pnas.87.1.182 1:CAS:528:DyaK3cXhtFaktLs%3D (Pubitemid 20033032)
31. KA Gruber MF Callahan 1989 ACTH (4-10) through γ-MSH: evidence for a new class of central autonomic nervous system-regulating peptides Am. J. Phys 257 R681 R694 1:CAS:528:DyaL1MXmt1GgtLs%3D
32. MC Klein PM Hutchins JR Lymangrover KA Gruber 1985 Pressor and cardioaccelerator effects of gamma MSH and related peptides Life Sci. 36 769 775 2983170 10.1016/0024-3205(85)90197-3 1:CAS:528:DyaL2MXht1Gksb4%3D (Pubitemid 15165270)
33. DH Versteeg P Van Bergen RA Adan DJ De Wildt 1998 Melanocortins and cardiovascular regulation Eur. J. Pharmacol. 360 1 14 9845266 10.1016/S0014-2999(98)00615-3 1:CAS:528:DyaK1cXns1amt7Y%3D (Pubitemid 28529390)
34. M Allard S Labrouche A Nosjean R Laguzzi 1995 Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat J. Pharmacol. Exp. Ther. 274 577 583 7616447 1:CAS:528:DyaK2MXntVWlu74%3D
35. C Thiemermann S al-Damluji M Hecker JR Vane 1991 FMRF-amide and l-Arg-l-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system Biochem. Biophys. Res. Commun. 175 318 324 1998514 10.1016/S0006-291X(05)81237-9 1:CAS:528: DyaK3MXhslynurw%3D
36. Z Zukowska-Grojec ES Marks M Haass 1987 Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat Am. J. Physiol. 253 H1234 H1239 3688263 1:CAS:528:DyaL1cXjt1KrtA%3D%3D
37. Z. Zukowska-Grojec, C. Wahlestedt, Origin and actions of neuropeptide Y in the cardiovascular system. in The biology of neuropeptide Y and related peptides, ed. by W.F. Colmers, C. Wahlestedt (Humana Press, 1993), pp. 315-388
38. AP Serone JA Angus 1999 Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria Br. J. Pharmacol. 127 383 390 10385237 10.1038/sj.bjp.0702565 1:CAS:528:DyaK1MXjs1yqsL8%3D (Pubitemid 29245675)
39. MA Smith-White TP Iismaa EK Potter 2003 Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse Br. J. Pharmacol. 140 170 178 12967946 10.1038/sj.bjp.0705404 1:CAS:528: DC%2BD3sXnsFyltrw%3D (Pubitemid 37175842)
40. MA Smith-White H Herzog EK Potter 2002 Cardiac function in neuropeptide Y Y4 receptor-knockout mice Regul. Pept. 31 47 54 10.1016/S0167-0115(02)00160-X (Pubitemid 35435332)
41. JR Martin 2004 The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat Brain Res. 1002 11 20 14988028 10.1016/j.brainres.2003.12.002 1:CAS:528:DC%2BD2cXhsVOms7k%3D (Pubitemid 38258298)
42. MF Callahan JT Cunningham RF Kirby AK Johnson KA Gruber 1988 Role of the anteroventral third ventricle (AV3 V) region of the rat brain in the pressor response to gamma 2-melanocyte-stimulating hormone (gamma 2-MSH) Brain Res. 444 177 180 3359287 10.1016/0006-8993(88)90925-0 1:CAS:528:DyaL1cXhs1Wku7o%3D (Pubitemid 18071206)
43. WE Hoffman MI Phillips 1976 Evidence for sar1-ala8-angiotensin crossing the blood cerebrospinal fluid barrier to antagonize central effects of angiotensin II Brain Res. 109 541 552 1276934 10.1016/0006-8993(76)90033-0 1:CAS:528:DyaE28Xkslaltbw%3D
44. J Buggy AK Johnson 1978 Angiotensin-induced thirst, effects of third ventricle obstruction and periventricular ablation Brain Res. 149 117 128 656950 10.1016/0006-8993(78)90592-9 1:CAS:528:DyaE1cXltVSltr8%3D (Pubitemid 8350028)
45. J Duhault M Boulanger S Chamorro JA Boutin O Della Zuana E Douillet JL Fauchere M Feletou M Germain B Husson AM Vega P Renard F Tisserand 2000 Food intake regulation in rodents, Y5 or Y1 NPY receptors or both? Can. J. Physiol. Pharmacol. 78 173 185 10737680 10.1139/cjpp-78-2-173 1:CAS:528: DC%2BD3cXhsVKnsro%3D
46. D Capurro JP Huidobro-Toro 1999 The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex, studies with BIBP 3226 and BIBO 3304 Eur. J. Pharmacol. 376 251 255 10448884 10.1016/S0014-2999(99)00392-1 1:CAS:528:DyaK1MXlt1Onsbg%3D (Pubitemid 29320150)
47. LH Shin PS Dovgan TJ Nypaver OA Carretero WH Beierwaltes 2000 Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat J. Vasc. Surg. 32 1015 1021 11054234 10.1067/mva.2000.108642 1:STN:280:DC%2BD3M%2FltlGqsg%3D%3D (Pubitemid 30839866)
48. AM Coney JM Marshall 2007 Contribution of {alpha}2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat J. Physiol. 582 1349 1359 17510186 10.1113/jphysiol.2007.132563 1:CAS:528:DC%2BD2sXhtVKqtbrP
49. F Simonin M Schmitt JP Laulin E Laboureyras JH Jhamandas D MacTavish A Matifas C Mollereau P Laurent M Parmentier BL Kieffer JJ Bourguignon G Simonnet 2006 RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia Proc. Natl. Acad. Sci. USA 103 466 471 16407169 10.1073/pnas.0502090103 1:CAS:528:DC%2BD28XpsVSksQ%3D%3D (Pubitemid 43122424)
50. S Takayasu T Sakurai S Iwasaki H Teranishi A Yamanaka SC Williams H Iguchi YI Kawasawa Y Ikeda I Sakakibara K Ohno RX Ioka S Murakami N Dohmae J Xie T Suda T Motoike T Ohuchi M Yanagisawa J Sakai 2006 A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice Proc. Natl. Acad. Sci. USA 103 7438 7443 16648250 10.1073/pnas.0602371103 1:CAS:528:DC%2BD28XkslOrt78%3D (Pubitemid 43727851)
51. DA Keire P Mannon M Kobayashi JH Walsh TE Solomon JR Reeve Jr 2000 Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity Am. J. Physiol. Gastrointest. Liver Physiol. 279 G126 G131 10898754 1:CAS:528:DC%2BD3cXltl2jtr4%3D
52. GD Nielsen 1977 Influence of various anaesthetics on the cardiovascular responses to noradrenaline in rats before and after guanethidine Acta Pharmacol. Toxicol. (Copenh) 40 75 86 1:CAS:528:DyaE2sXhtleltLs%3D
53. K Hara RA Harris 2002 The anesthetic mechanism of urethane, the effects on neurotransmitter-gated ion channels Anesth. Analg. 94 313 318 11812690 10.1097/00000539-200202000-00015 1:CAS:528:DC%2BD38XhtlehsbY%3D
54. DN Jackson EG Noble JK Shoemacker 2004 Y1 and alpha-1 control of basal hindlimb vascuylar tone Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 R228 R233 15044188 1:CAS:528:DC%2BD2cXmtVeksbs%3D
55. NU Qureshi EK Dayao S Shirali Z Zukowska-Grojec GJ Hauser 1998 Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock Regul. Pept. 75-76 215 220 9802412 10.1016/S0167-0115(98)00071-8 (Pubitemid 28477530)
56. W Zhang JM Lundberg P Thoren 1997 Neuropeptide Y Y1 receptor antagonist (BIBP 3226) attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats Cardiovasc. Drugs Ther. 11 801 806 9512876 10.1023/A:1007726626924 1:CAS:528:DyaK1cXhsF2gsLs%3D (Pubitemid 28056997)
57. K Rudolf W Eberlein W Engel HA Wieland KD Willim M Entzeroth W Wienen AG Beck-Sickinger HN Doods 1994 The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 Eur. J. Pharmacol. 271 R11 R13 7705422 10.1016/0014-2999(94)90822-2 1:CAS:528:DyaK2MXjt1Sntrw%3D
58. Z Zukowska-Grojec EK Dayao E Karwatowska-Prokopczuk GJ Hauser HN Doods 1996 Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors Am. J. Physiol. 270 H796 H800 8779858 1:CAS:528:DyaK28Xhs1ajurk%3D
59. N.A. Dyson, in Chromatographic Integration Methods, chapter 3, (Royal Society of Chemistry, London, 1998), pp. 95-103
60. BA Eipper RE Mains 1980 Structure and biosynthesis of pro-adrenocorticotropin/endophin and related peptides Endocr. Rev. 1 1 6262069 10.1210/edrv-1-1-1 1:CAS:528:DyaL3cXksVahtrY%3D
61. AI Smith JW Funder 1988 Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues Endocr. Rev. 9 159 179 3286233 10.1210/edrv-9-1-159 1:CAS:528:DyaL1cXhs1Wnu7w%3D
62. L Roselli-Rehfuss KG Mountjoy LS Robbins MT Mortrud MJ Low JB Tatro ML Entwistle RB Simerly RD Cone 1993 Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system Proc. Natl. Acad. Sci. USA 90 8856 8860 8415620 10.1073/pnas.90.19.8856 1:STN:280:DyaK2c%2Fit1aksQ%3D%3D (Pubitemid 23306409)
63. Y Dumont E Moyse A Founier R Quirion 2005 Evidence for the existance of an additional class of neuropeptide Y receptor sites in rat brain J. Pharmacol. Exp. Ther. 315 99 108 15947033 10.1124/jpet.105.089300 1:CAS:528: DC%2BD2MXhtVOks77P (Pubitemid 41380502)
64. AK Johnson WE Hoffman J Buggy 1978 Attenuated pressor responses to intracranially injected stimuli and altered antidiuretic activity following preoptic-hypothalamic periventricular ablation Brain Res. 157 161 166 698843 10.1016/0006-8993(78)91007-7 1:STN:280:DyaE1M%2Fit1Gqsg%3D%3D (Pubitemid 9031903)
65. E Grazzini C Puma MO Roy XH Yu D O'Donnell R Schmidt S Dautrey J Ducharme M Perkins R Panetta JM Laird S Ahmad PM Lembo 2004 Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats Proc. Natl. Acad. Sci. USA 101 7175 7180 15118101 10.1073/pnas.0307185101 1:CAS:528:DC%2BD2cXktFeqsbc%3D (Pubitemid 38596462)
66. Y Jiang L Luo EL Gustafson D Yadav M Laverty N Murgolo G Vassileva M Zeng TM Laz J Behan P Qiu L Wang S Wang M Bayne J Greene F Monsma Jr FL Zhang 2003 Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155 J. Biol. Chem. 278 27652 27657 12714592 10.1074/jbc.M302945200 1:CAS:528:DC%2BD3sXlsFKkt7s%3D (Pubitemid 36899952)
67. M Engstrom A Brandt S Wurster JM Savola P Panula 2003 Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors J. Pharmacol. Exp. Ther. 305 825 832 12606605 10.1124/jpet.102.047118 (Pubitemid 36617957)
68. WK Samson ZT Resch TC Murphy 2000 A novel action of the newly described prolactin-releasing peptides, cardiovascular regulation Brain Res. 858 19 25 10700591 10.1016/S0006-8993(99)02451-8 1:CAS:528:DC%2BD3cXhsVait7s%3D (Pubitemid 30105776)
69. Y Hu JC Dunbar 1997 Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds Brain Res. Bull. 44 97 103 9288836 10.1016/S0361-9230(97)00101-9 1:CAS:528:DyaK2sXmtVGmtL8%3D (Pubitemid 27375181)